Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1021

1.

A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation.

Kosaka T, Hongo H, Aimono E, Matsumoto K, Hayashida T, Mikami S, Nishihara H, Oya M.

Pathol Int. 2019 Oct 20. doi: 10.1111/pin.12860. [Epub ahead of print]

PMID:
31631483
2.

Heterogeneity of tyrosine hydroxylase expressing neurons in the main olfactory bulb of the mouse.

Kosaka T, Pignatelli A, Kosaka K.

Neurosci Res. 2019 Oct 17. pii: S0168-0102(19)30471-7. doi: 10.1016/j.neures.2019.10.004. [Epub ahead of print]

PMID:
31629793
3.

Refractory chronic subdural hematoma associated with dural metastasis of lung adenocarcinoma treated with endovascular embolization for the middle meningeal artery: a case report.

Kosaka T, Ikeda N, Furuse M, Nonoguchi N, Hiramatsu R, Yagi R, Kawabata S, Miyachi S, Kuroiwa T, Wanibuchi M.

World Neurosurg. 2019 Oct 16. pii: S1878-8750(19)32650-6. doi: 10.1016/j.wneu.2019.10.035. [Epub ahead of print]

PMID:
31629135
4.

Photo-responsive materials with strong cell trapping ability for light-guided manipulation of nonadherent cells.

Jarzębska NT, Yamaguchi S, Izuta S, Kosaka T, Yamahira S, Nagamune T, Okamoto A.

Biomater Sci. 2019 Nov 1;7(11):4514-4518. doi: 10.1039/c9bm01200a. Epub 2019 Oct 11.

PMID:
31602442
5.

Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy.

Matsumoto K, Niwa N, Hagiwara M, Kosaka T, Tanaka N, Takeda T, Morita S, Mizuno R, Shinojima T, Hara S, Asanuma H, Oya M.

World J Urol. 2019 Sep 26. doi: 10.1007/s00345-019-02970-w. [Epub ahead of print]

PMID:
31559475
6.

Curative-Intent Surgery for Stage IV Advanced Gastric Cancer: Who Can Undergo Surgery and What Are the Prognostic Factors for Long-Term Survival?

Sato S, Kunisaki C, Tanaka Y, Sato K, Miyamoto H, Yukawa N, Kosaka T, Akiyama H, Endo I, Misumi T.

Ann Surg Oncol. 2019 Sep 16. doi: 10.1245/s10434-019-07790-1. [Epub ahead of print]

PMID:
31529308
7.

A Complete Response Achieved in a Patient with Hepatic Metastasis from Sigmoid Colon Cancer by a Regimen Containing Ramucirumab: a Case Report.

Fukui S, Kobayashi K, Morita M, Ito S, Inoue Y, Kuba S, Sakimura C, Kosaka T, Abe K, Yamanouchi K, Kanetaka K, Takatsuki M, Eguchi S.

J Gastrointest Cancer. 2019 Sep 3. doi: 10.1007/s12029-019-00304-y. [Epub ahead of print] No abstract available.

PMID:
31482405
8.

[The Efficacy of the Emergent Shunt-Clamp System for Secondary Hydrocephalus Associated with Fourth Ventricle Outlet Obstruction Syndrome:A Report of Two Cases].

Kambara A, Ikeda N, Ihata T, Kosaka T, Park Y, Ohmura N, Furuse M, Nonoguchi N, Kawabata S, Kajimoto Y, Kuroiwa T.

No Shinkei Geka. 2019 Aug;47(8):893-900. doi: 10.11477/mf.1436204041. Japanese.

PMID:
31477633
9.

Long-term complete response in a patient with postoperative recurrent ALK-rearranged lung adenocarcinoma treated with crizotinib: A case report.

Kosaka T, Yajima T, Yamaki E, Nakazawa S, Tomizawa K, Onozato R, Yamazaki A, Hirato J, Yatabe Y, Shimizu K, Mogi A, Shirabe K.

Mol Clin Oncol. 2019 Sep;11(3):309-312. doi: 10.3892/mco.2019.1892. Epub 2019 Jul 3.

10.
11.

Impact of pegfilgrastim as primary prophylaxis for metastatic castration-resistant prostate cancer patients undergoing cabazitaxel treatment: an open-label study in Japan.

Kosaka T, Uemura H, Sumitomo M, Harada K, Sugimoto M, Hayashi N, Yoshimura K, Fukasawa S, Ecstein-Fraisse E, Sunaga Y, Oya M.

Jpn J Clin Oncol. 2019 Apr 26. pii: hyz051. doi: 10.1093/jjco/hyz051. [Epub ahead of print]

PMID:
31329922
12.

Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy.

Watanabe K, Kosaka T, Aimono E, Hongo H, Mikami S, Nishihara H, Oya M.

Clin Genitourin Cancer. 2019 Oct;17(5):e897-e902. doi: 10.1016/j.clgc.2019.06.005. Epub 2019 Jun 13. No abstract available.

PMID:
31296452
13.

MIG1 as a positive regulator for the histidine biosynthesis pathway and as a global regulator in thermotolerant yeast Kluyveromyces marxianus.

Nurcholis M, Murata M, Limtong S, Kosaka T, Yamada M.

Sci Rep. 2019 Jul 9;9(1):9926. doi: 10.1038/s41598-019-46411-5.

14.

TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells.

Niwa N, Tanaka N, Hongo H, Miyazaki Y, Takamatsu K, Mizuno R, Kikuchi E, Mikami S, Kosaka T, Oya M.

Lab Invest. 2019 Jul 1. doi: 10.1038/s41374-019-0285-y. [Epub ahead of print]

PMID:
31263157
15.

The neutrophil/lymphocyte ratio as a predictor of peritoneal metastasis during staging laparoscopy for advanced gastric cancer: a retrospective cohort analysis.

Nakamura N, Kinami S, Fujii Y, Miura S, Fujita J, Kaida D, Tomita Y, Miyata T, Fujita H, Ueda N, Iida Y, Kosaka T.

World J Surg Oncol. 2019 Jun 25;17(1):108. doi: 10.1186/s12957-019-1651-3.

16.

Correction: Capacity for survival in global warming: Adaptation of mesophiles to the temperature upper limit.

Kosaka T, Nakajima Y, Ishii A, Yamashita M, Yoshida S, Murata M, Kato K, Shiromaru Y, Kato S, Kanesaki Y, Yoshikawa H, Matsutani M, Thanonkeo P, Yamada M.

PLoS One. 2019 Jun 20;14(6):e0218985. doi: 10.1371/journal.pone.0218985. eCollection 2019.

17.

An Aggregation-defective Mutant of Methanothermobacter sp. CaT2 Reveals Unique Protein-dependent Aggregation.

Sumikawa K, Kosaka T, Mayahara N, Matsutani M, Udo K, Yamada M.

Microbes Environ. 2019 Sep 25;34(3):244-251. doi: 10.1264/jsme2.ME19014. Epub 2019 Jun 13.

19.

Essential human resources for antimicrobial stewardship teams in Japan: Estimates from a nationwide survey conducted by the Japanese Society of Chemotherapy.

Maeda M, Muraki Y, Kosaka T, Yamada T, Aoki Y, Kaku M, Seki M, Tanabe Y, Fujita N, Niki Y, Morita K, Yanagihara K, Yoshida K, Kawaguchi T.

J Infect Chemother. 2019 Sep;25(9):653-656. doi: 10.1016/j.jiac.2019.05.012. Epub 2019 Jun 7.

PMID:
31182329
20.

Will minimally invasive sleeve resection become the future trend for treatment of advanced lung cancer?

Kosaka T, Shimizu K, Nakazawa S, Obayashi K, Ohtaki Y, Kawatani N, Ibe T, Yajima T, Mogi A, Shirabe K.

J Thorac Dis. 2019 Apr;11(4):1085-1087. doi: 10.21037/jtd.2019.02.95. No abstract available.

21.

Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers.

Aikawa A, Fujita H, Kosaka T, Minato H, Kiyokawa E.

Cancer Sci. 2019 Aug;110(8):2667-2675. doi: 10.1111/cas.14093. Epub 2019 Jun 22.

22.

Impact of inappropriate empiric antimicrobial therapy on mortality in pediatric patients with bloodstream infection: a retrospective observational study.

Kyo M, Ohshimo S, Kosaka T, Fujita N, Shime N.

J Chemother. 2019 May 30:1-6. doi: 10.1080/1120009X.2019.1623362. [Epub ahead of print]

PMID:
31145044
23.

IVC angioplasty using an autologous vascular graft for IVC stenosis due to metallic stent in a pediatric liver transplant.

Kosaka T, Eguchi S, Hidaka M, Adachi T, Yoshino K, Kanetaka K, Takatsuki M, Ito S.

Pediatr Transplant. 2019 Aug;23(5):e13475. doi: 10.1111/petr.13475. Epub 2019 May 24.

PMID:
31124585
24.

Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients.

Takamatsu K, Mizuno R, Tanaka N, Takeda T, Morita S, Matsumoto K, Kosaka T, Shinojima T, Kikuchi E, Asanuma H, Oyama M, Mikami S, Oya M.

Int J Clin Oncol. 2019 Sep;24(9):1069-1074. doi: 10.1007/s10147-019-01459-1. Epub 2019 May 7.

PMID:
31065836
25.

Capacity for survival in global warming: Adaptation of mesophiles to the temperature upper limit.

Kosaka T, Nakajima Y, Ishii A, Yamashita M, Yoshida S, Murata M, Kato K, Shiromaru Y, Kato S, Kanasaki Y, Yoshikawa H, Matsutani M, Thanonkeo P, Yamada M.

PLoS One. 2019 May 7;14(5):e0215614. doi: 10.1371/journal.pone.0215614. eCollection 2019. Erratum in: PLoS One. 2019 Jun 20;14(6):e0218985.

26.

A case of early myoclonic encephalopathy with intractable seizures successfully treated with high-dose phenobarbital.

Kosaka T, Ohta G, Kometani H, Kawatani M, Ohshima Y.

Brain Dev. 2019 Sep;41(8):717-720. doi: 10.1016/j.braindev.2019.04.007. Epub 2019 Apr 23.

PMID:
31027651
27.

Precision surgical approach with lymph-node dissection in early gastric cancer.

Kinami S, Nakamura N, Tomita Y, Miyata T, Fujita H, Ueda N, Kosaka T.

World J Gastroenterol. 2019 Apr 14;25(14):1640-1652. doi: 10.3748/wjg.v25.i14.1640. Review.

28.

A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases.

Nakamura N, Kinami S, Fujii Y, Miura S, Fujita J, Kaida D, Tomita Y, Miyata T, Fujita H, Ueda N, Kosaka T.

Clin Case Rep. 2019 Feb 26;7(4):714-718. doi: 10.1002/ccr3.2056. eCollection 2019 Apr.

29.

The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy.

Takamatsu K, Matsumoto K, Shojo K, Tanaka N, Takeda T, Morita S, Kosaka T, Mizuno R, Shinojima T, Kikuchi E, Asanuma H, Oya M.

Urol Oncol. 2019 Sep;37(9):575.e19-575.e25. doi: 10.1016/j.urolonc.2019.03.012. Epub 2019 Apr 6.

PMID:
30967332
30.

Medial-basal segment (S7)-sparing right basal segmentectomy.

Yajima T, Shimizu K, Mogi A, Kosaka T, Nakazawa S, Shirabe K.

Gen Thorac Cardiovasc Surg. 2019 Apr 1. doi: 10.1007/s11748-019-01116-4. [Epub ahead of print]

PMID:
30937818
31.

Factors Influencing the Changes in Masticatory Performance: The Suita Study.

Kosaka T, Kida M, Kikui M, Hashimoto S, Fujii K, Yamamoto M, Nokubi T, Maeda Y, Hasegawa Y, Kokubo Y, Watanabe M, Higashiyama A, Miyamoto Y, Ono T.

JDR Clin Trans Res. 2018 Oct;3(4):405-412. doi: 10.1177/2380084418785863. Epub 2018 Jun 27.

PMID:
30931790
32.

Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma.

Iijima M, Yokobori T, Mogi A, Shimizu K, Yajima T, Kosaka T, Ohtaki Y, Obayashi K, Nakazawa S, Gombodorj N, Tsukagoshi M, Shirabe K, Kuwano H.

Ann Surg Oncol. 2019 Jun;26(6):1744-1750. doi: 10.1245/s10434-019-07268-0. Epub 2019 Mar 28.

PMID:
30924018
33.

Flagellum-mediated motility in Pelotomaculum thermopropionicum SI.

Kosaka T, Goda M, Inoue M, Yakushi T, Yamada M.

Biosci Biotechnol Biochem. 2019 Jul;83(7):1362-1371. doi: 10.1080/09168451.2019.1597618. Epub 2019 Mar 28.

PMID:
30919743
34.

Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer.

Kosaka T, Akiyama H, Miyamoto H, Sato S, Tanaka Y, Sato K, Kunisaki C, Endo I.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1047-1055. doi: 10.1007/s00280-019-03813-6. Epub 2019 Mar 25.

PMID:
30911769
35.

Tumor Volume Index as a Prognostic Factor in Patients after Curative Esophageal Cancer Resection.

Miyamoto H, Kunisaki C, Sato S, Tanaka Y, Sato K, Kosaka T, Yukawa N, Akiyama H, Saigusa Y, Endo I.

Ann Surg Oncol. 2019 Jun;26(6):1909-1915. doi: 10.1245/s10434-019-07308-9. Epub 2019 Mar 19.

PMID:
30891629
36.

Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.

Uemura H, Uemura H, Nagamori S, Wakumoto Y, Kimura G, Kikukawa H, Yokomizo A, Mizokami A, Kosaka T, Masumori N, Kawasaki Y, Yonese J, Nasu Y, Fukasawa S, Sugiyama T, Kinuya S, Hosono M, Yamaguchi I, Akagawa T, Matsubara N.

Int J Clin Oncol. 2019 May;24(5):557-566. doi: 10.1007/s10147-018-01389-4. Epub 2019 Mar 14.

37.

Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas.

Ohtaki Y, Shimizu K, Kawabata-Iwakawa R, Gombodorj N, Altan B, Rokudai S, Yamane A, Kaira K, Yokobori T, Nagashima T, Obayashi K, Nakazawa S, Iijima M, Kosaka T, Yajima T, Mogi A, Kuwano H, Shirabe K, Nishiyama M.

Oncotarget. 2019 Feb 12;10(13):1306-1319. doi: 10.18632/oncotarget.26657. eCollection 2019 Feb 12.

38.

Tooth loss leads to reduced nutrient intake in middle-aged and older Japanese individuals.

Kosaka T, Kida M.

Environ Health Prev Med. 2019 Mar 5;24(1):15. doi: 10.1186/s12199-019-0770-3.

39.

Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration.

Shigeta K, Kosaka T, Hongo H, Yanai Y, Matsumoto K, Morita S, Mizuno R, Shinojima T, Kikuchi E, Oya M.

Int J Clin Oncol. 2019 May;24(5):554-556. doi: 10.1007/s10147-019-01395-0.

PMID:
30826960
40.

Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer.

Matsumoto K, Akita H, Narita K, Hashiguchi A, Takamatsu K, Takeda T, Kosaka T, Mizuno R, Kikuchi E, Oya M, Jinzaki M.

Prostate Cancer Prostatic Dis. 2019 Feb 27. doi: 10.1038/s41391-019-0136-3. [Epub ahead of print]

PMID:
30814680
41.

Sulfasalazine could modulate the CD44v9-xCT system and enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer.

Ogihara K, Kikuchi E, Okazaki S, Hagiwara M, Takeda T, Matsumoto K, Kosaka T, Mikami S, Saya H, Oya M.

Cancer Sci. 2019 Apr;110(4):1431-1441. doi: 10.1111/cas.13960. Epub 2019 Mar 1.

42.

Fas/FasL signaling is critical for the survival of exhausted antigen-specific CD8+ T cells during tumor immune response.

Yajima T, Hoshino K, Muranushi R, Mogi A, Onozato R, Yamaki E, Kosaka T, Tanaka S, Shirabe K, Yoshikai Y, Kuwano H.

Mol Immunol. 2019 Mar;107:97-105. doi: 10.1016/j.molimm.2019.01.014. Epub 2019 Jan 30.

PMID:
30711908
43.

[A Case of Sigmoid Cancer with Six Asynchronistic Metastases to Multiple Organs That Were Resected through Four Surgeries].

Ueda N, Fujii Y, Miura S, Fujita J, Tomita Y, Fujita H, Kinami S, Kosaka T, Usuda K, Uramoto H.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2081-2083. Japanese.

PMID:
30692291
44.

Sealed endoscopic full-thickness resection for gastric cancer: a pilot study in an ex vivo and in vivo porcine model.

Kitakata H, Itoh T, Kinami S, Kawaura K, Hamada K, Azukisawa S, Kobayashi R, Kamai J, Kosaka T.

Endosc Int Open. 2019 Jan;7(1):E36-E42. doi: 10.1055/a-0777-1954. Epub 2019 Jan 3.

45.

Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration.

Shigeta K, Kosaka T, Hongo H, Yanai Y, Matsumoto K, Morita S, Mizuno R, Shinojima T, Kikuchi E, Oya M.

Int J Clin Oncol. 2019 May;24(5):546-553. doi: 10.1007/s10147-018-01388-5. Epub 2019 Jan 2. Erratum in: Int J Clin Oncol. 2019 Mar 2;:.

PMID:
30604159
46.

Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions.

Sugiura Y, Takeo E, Shimma S, Yokota M, Higashi T, Seki T, Mizuno Y, Oya M, Kosaka T, Omura M, Nishikawa T, Suematsu M, Nishimoto K.

Hypertension. 2018 Dec;72(6):1345-1354. doi: 10.1161/HYPERTENSIONAHA.118.11243.

PMID:
30571232
47.

Risk stratification of castration-resistant prostate cancer patients treated with cabazitaxel.

Kosaka T, Hongo H, Mizuno R, Oya M.

Mol Clin Oncol. 2018 Dec;9(6):683-688. doi: 10.3892/mco.2018.1724. Epub 2018 Sep 19.

48.

Evaluation of prostate-specific antigen density in the diagnosis of prostate cancer combined with magnetic resonance imaging before biopsy in men aged 70 years and older with elevated PSA.

Yanai Y, Kosaka T, Hongo H, Matsumoto K, Shinojima T, Kikuchi E, Miyajima A, Mizuno R, Mikami S, Jinzaki M, Oya M.

Mol Clin Oncol. 2018 Dec;9(6):656-660. doi: 10.3892/mco.2018.1725. Epub 2018 Sep 19.

49.

Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study.

Koga T, Kobayashi Y, Tomizawa K, Suda K, Kosaka T, Sesumi Y, Fujino T, Nishino M, Ohara S, Chiba M, Shimoji M, Takemoto T, Suzuki M, Jänne PA, Mitsudomi T.

Lung Cancer. 2018 Dec;126:72-79. doi: 10.1016/j.lungcan.2018.10.019. Epub 2018 Oct 17.

PMID:
30527195
50.

A Phase II Study of Tri-weekly Low-dose Nab-paclitaxel Chemotherapy for Patients with Advanced Gastric Cancer.

Sato S, Kunisaki C, Tanaka Y, Sato K, Miyamoto H, Yukawa N, Fujii Y, Kimura J, Takagawa R, Takahashi M, Kosaka T, Akiyama H, Saigusa Y, Taguri M, Yamanaka T, Endo I.

Anticancer Res. 2018 Dec;38(12):6911-6917. doi: 10.21873/anticanres.13068.

PMID:
30504409

Supplemental Content

Loading ...
Support Center